Search results
As ketamine therapy booms, industry insiders worry about patient safety
Market Watch· 7 days agoThe incident raises broader questions about at-home ketamine therapy, the doctors wrote. Guidelines...
The long-term health risks of ketamine, including bladder issues
Yahoo Life UK· 3 days agoWith there an increase in 'ketamine bladder' among young people, what other problems can excessive...
Utah woman finds relief from depression with ketamine therapy
KSL Salt Lake City· 3 days agoThis story is sponsored by Anew Therapy. What if your depression could improve radically in a matter...
...) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for ...
KTLA-TV Los Angeles· 2 days agoNRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this sample size) and 75% advantage in relief from Akathisia ...
Can Esketamine Prevent Postpartum Depression?
Medscape· 6 days agoData suggest that a low dose of esketamine immediately after childbirth reduces major depressive episodes in women with prenatal depression.
At least 17 people died in Florida after medics injected sedatives during encounters with police
ABC Action News Tampa Bay· 6 days agoAt least 17 people died in Florida over a decade following a physical encounter with police during which medical personnel also injected them with a powerful sedative, an investigation led by ...
Psychedelic Tx: What Meaningful Informed Consent Looks Like
Medscape· 2 days agoThe US Food and Drug Administration has designated psilocybin and 3,4-methylenedioxymethamphetamine...
DEA’s Psychedelic-Outlawing Effort Attacked by Private Industry | The Legal Intelligencer
Law.com· 3 days agoDespite the U.S. Food and Drug Administration’s approval of depression treatment drug Esketamine and...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoThe first phase of the collaboration comprises an in-depth information exchange on the COMP360 psilocybin treatment delivery model.
NRX-101 shows promise in bipolar depression trial By Investing.com
Investing.com· 2 days agoNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) has reported findings from a clinical trial suggesting that...